Renal replacement therapy in end-stage sickle cell nephropathy: presentation of two cases and literature review.
Chronic renal failure develops in 4-18% of patients with sickle cell anemia. Hemodialysis and kidney transplant are viable options in the management of end-stage renal disease in patients with sickle cell disease (SCD). Information on kidney disease among Saudi patients with SCD is non-existing. In this report, the clinical course of two adult males with end-stage sickle cell nephropathy from Eastern Saudi Arabia is described. Literature on renal replacement therapy in sickle cell anemia (SCA) is discussed.
Al-Mueilo
Samir H
SH
Department of Internal Medicine, King Fahd Hospital of the University, Alkhobar, Saudi Arabia.